1) Pharmaceutical Affairs Law
《药事管理法》
1.
Objective:To provide suggestions for China in revising"Pharmaceutical Affairs Law"Methods:Through consulting the FD&CA and the FDA Import Procedures,the study was done by reviewing literature and comparison study.
目的:为我国《药事管理法》修订提供建议。
2) pharmaceutical law and regulation
药事管理法规
3) pharmaceutical administration and regulation
药事管理与法规
1.
This article describes the application of The Chinese Medicine Cocktail(CMC) research on innovative teaching mode in pharmaceutical administration and regulation course in vocational colleges.
本文对高职院校生物制药方向专业课《药事管理与法规》课程创新教学模式进行了探讨。
4) pharmaceutical administration
药事管理
1.
This thesis discussed the research methods, explained the importance of transplant method and analyzed the relationship among the methods used in pharmaceutical administration and economics.
药事管理学科发展过程中 ,基础研究应得到应有的重视。
2.
Pharmaceutical administration (PA) is a branch of social administration and it also grows from simply and elementarily to complicatedly and highly with the development of social economy and pharmacy.
药事管理是社会管理的一个分支。
3.
ObjectiveThe hot spots and issues of pharmaceutical administration were focusing onstatistical analysis in China,to find a reasonable starting point for further research.
目的对我国药事管理热点、重点问题进行统计分析,找到进一步研究的合理切入点。
5) pharmacy administration
药事管理
1.
Some teaching experience in the pharmacy administration;
对《药事管理学》的几点教学体会
2.
Comparison of Study Development of Pharmacy Administration between the Mainland,HongKong,Macao and Taiwan in China;
中国内地及港澳台地区药事管理研究动态介绍
3.
Exploration on Cultivating Postgraduates of Pharmacy Administration;
培养药事管理硕士研究生的探索
6) Pharmaceutical management
药事管理
1.
Based on the current status analysis,the article provided some measures of pharmaceutical management of sanitarium.
本文分析疗养院药事管理的现状,认为疗养院的药事管理应当依据疗养院的特性和药物治疗的特点,寻找疗养院药事管理的基础,突出疗养院的特色、内容和方法,发挥优势,走有别于医院的道路,目标应是纠正药物滥用、用药方案个体化、群体药物监测和提高用药依从性。
补充资料:[3-(aminosulfonyl)-4-chloro-N-(2.3-dihydro-2-methyl-1H-indol-1-yl)benzamide]
分子式:C16H16ClN3O3S
分子量:365.5
CAS号:26807-65-8
性质:暂无
制备方法:暂无
用途:用于轻、中度原发性高血压。
分子量:365.5
CAS号:26807-65-8
性质:暂无
制备方法:暂无
用途:用于轻、中度原发性高血压。
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条